BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
VEGFA
,
glucose metabolic process
,
Allergy to pollen
,
Endothelial cell
,
Doxycycline
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
14 3- 3 eta
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for 14 3- 3 eta
Explore Curated Studies Results
Literature
Most Relevant Literature
Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazol…
METTL14 promotes neuroblastoma formation by inhibiting YWHAH via an m6A-YTHDF1-dependent mechanism.
Inhibiting miR-33b-5p Enhances Chemoresistance in Lung Adenocarcinoma by Targeting YWHAH to Regulate…
LINC00943 regulates miR-1252-5p/YWHAH axis to promote tumor proliferation and metastasis in lung ade…
Circ_0000144 acts as a miR-1178-3p decoy to promote cell malignancy and angiogenesis by increasing Y…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Assessment of 14-3-3 η (Eta) Protein Antibodies in the Serum of Rheumatoid Arthritis Patients and It…
EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2
A Study On the Risk of Nosocomial Infection in Mechanically Ventilated Neonate In NICU of Assiut Uni…
Relationship of YWHAH Polymorphisms to Rheumatoid Arthritis Disease Severity
VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ